Binding affinity and specificity of Escherichia coli RNase H1: impact on the kinetics of catalysis of antisense oligonucleotide-RNA hybrids
- PMID: 9003192
- DOI: 10.1021/bi962230p
Binding affinity and specificity of Escherichia coli RNase H1: impact on the kinetics of catalysis of antisense oligonucleotide-RNA hybrids
Abstract
In this study we report for the first time the binding affinity of RNase H1 for oligonucleotide duplexes. We used a previously described 17-mer antisense sequence [Monia, B. P., Johnston, J. F., Ecker, D. J., Zounes, M. A., Lima, W. F., & Freier, S. M. (1992) J. Biol. Chem. 267, 19954-19962] hybridized to a complementary oligoribonucleotide to evaluate both the binding affinity and the catalytic rate of RNase H1. The dissociation constants (Kd) of RNase H1 for the various substrates tested were determined by inhibition analysis using chemically modified noncleavable oligonucleotide heteroduplexes. Catalytic rates were determined using heteroduplex substrates containing chimeric antisense oligonucleotides composed of a five-base deoxynucleotide sequence flanked on either side by chemically modified nucleotides. We find that the enzyme preferentially binds A-form duplexes: RNase H bound A-form duplexes (RNA:RNA and DNA:RNA) approximately 60-fold tighter than B-form duplexes (DNA:DNA) and approximately 300-fold tighter than single-strand oligonucleotides. The enzyme exhibited equal affinity for both the wild type (RNA:DNA) oligonucleotide substrate and heteroduplexes containing various 2'-sugar modifications, while the cleavage rates for these chemically modified substrates were without exception slower than for the wild type substrate. The introduction of a single positively charged 2'-propoxyamine modification into the chimeric antisense oligonucleotide portion of the heteroduplex substrate resulted in both decreased binding affinity and a slower rate of catalysis by RNase H. The cleavage rates for heteroduplexes containing single-base mismatch sequences within the chimeric oligonucleotide portion varied depending on the position of the mismatch but had no effect on the binding affinity of the enzyme. These results offer further insights into the physical binding properties of the RNase H-substrate interaction as well as the design of effective antisense oligonucleotides.
Similar articles
-
Comparison of the RNase H cleavage kinetics and blood serum stability of the north-conformationally constrained and 2'-alkoxy modified oligonucleotides.Biochemistry. 2007 May 15;46(19):5635-46. doi: 10.1021/bi0620205. Epub 2007 Apr 6. Biochemistry. 2007. PMID: 17411072
-
Carba-LNA-5MeC/A/G/T modified oligos show nucleobase-specific modulation of 3'-exonuclease activity, thermodynamic stability, RNA selectivity, and RNase H elicitation: synthesis and biochemistry.J Org Chem. 2011 Jun 3;76(11):4408-31. doi: 10.1021/jo200073q. Epub 2011 May 4. J Org Chem. 2011. PMID: 21500818
-
The influence of antisense oligonucleotide-induced RNA structure on Escherichia coli RNase H1 activity.J Biol Chem. 1997 Jul 18;272(29):18191-9. doi: 10.1074/jbc.272.29.18191. J Biol Chem. 1997. PMID: 9218455
-
A critical survey of the structure-function of the antisense oligo/RNA heteroduplex as substrate for RNase H.J Biochem Biophys Methods. 2001 May 28;48(3):189-208. doi: 10.1016/s0165-022x(01)00149-x. J Biochem Biophys Methods. 2001. PMID: 11384757 Review.
-
An overview of sugar-modified oligonucleotides for antisense therapeutics.Chem Biodivers. 2011 Sep;8(9):1616-41. doi: 10.1002/cbdv.201100081. Chem Biodivers. 2011. PMID: 21922654 Review.
Cited by
-
Solution structure of an arabinonucleic acid (ANA)/RNA duplex in a chimeric hairpin: comparison with 2'-fluoro-ANA/RNA and DNA/RNA hybrids.Nucleic Acids Res. 2001 Nov 1;29(21):4284-93. doi: 10.1093/nar/29.21.4284. Nucleic Acids Res. 2001. PMID: 11691916 Free PMC article.
-
Dynamic NMR structures of [Rp]- and [Sp]-phosphorothioated DNA-RNA hybrids: is flexibility required for RNase H recognition?Biophys J. 2003 Oct;85(4):2525-38. doi: 10.1016/S0006-3495(03)74675-X. Biophys J. 2003. PMID: 14507715 Free PMC article.
-
Towards Personalized Allele-Specific Antisense Oligonucleotide Therapies for Toxic Gain-of-Function Neurodegenerative Diseases.Pharmaceutics. 2022 Aug 16;14(8):1708. doi: 10.3390/pharmaceutics14081708. Pharmaceutics. 2022. PMID: 36015334 Free PMC article. Review.
-
Likelihood of Nonspecific Activity of Gapmer Antisense Oligonucleotides Is Associated with Relative Hybridization Free Energy.Nucleic Acid Ther. 2020 Aug;30(4):215-228. doi: 10.1089/nat.2020.0847. Epub 2020 Mar 3. Nucleic Acid Ther. 2020. PMID: 32125928 Free PMC article.
-
Development of Antisense Drugs for Dyslipidemia.J Atheroscler Thromb. 2016 Sep 1;23(9):1011-25. doi: 10.5551/jat.RV16001. Epub 2016 Jul 27. J Atheroscler Thromb. 2016. PMID: 27466159 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous